{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:18:34Z","timestamp":1789787914604,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.pbb.2020.172918","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T19:25:03Z","timestamp":1585855503000},"page":"172918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018"],"prefix":"10.1016","volume":"193","author":[{"given":"Thomas F.","family":"Gamage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Barrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Kevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Lefever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvi R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Grabenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian F.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2020.172918_bb0005","series-title":"53rd Annual Meeting of the International Association of Forensic Toxicologists Meeting, Firenze, Italy","article-title":"5-F-cumyl-pinaca in \u201ce-liquids\u201d for electronic cigarettes\u2014a new type of synthetic cannabinoid in a trendy product","author":"Angerer","year":"2015"},{"issue":"10","key":"10.1016\/j.pbb.2020.172918_bb0010","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"10.1016\/j.pbb.2020.172918_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0149-7634(05)80051-X","article-title":"Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication","volume":"16","author":"Balster","year":"1992","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.pbb.2020.172918_bb0020","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/acschemneuro.5b00112","article-title":"Pharmacology of Indole and Indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA","volume":"6","author":"Banister","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.pbb.2020.172918_bb0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF02245942","article-title":"Pharmacological specificity of \u0394 9-tetrahydrocannabinol discrimination in rats","volume":"118","author":"Barrett","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.172918_bb0030","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1044-0305(02)00420-8","article-title":"A novel precursor ion discovery method on a hybrid quadrupole orthogonal acceleration time-of-flight (Q-TOF) mass spectrometer for studying protein phosphorylation","volume":"13","author":"Bateman","year":"2002","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.pbb.2020.172918_bb0035","first-page":"19","article-title":"Synthetic cannabinoid and cathinone use among US soldiers","author":"Berry-Caban","year":"2012","journal-title":"US Army Med Dep J"},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0040","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s11419-017-0368-7","article-title":"Mass spectrometric identification and structural analysis of the third-generation synthetic cannabinoids on the UK market since the 2013 legislative ban","volume":"35","author":"Bijlsma","year":"2017","journal-title":"Forensic Toxicology"},{"issue":"3","key":"10.1016\/j.pbb.2020.172918_bb0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1124\/jpet.113.206003","article-title":"Differential drug-drug interactions of the synthetic cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy","volume":"346","author":"Brents","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.pbb.2020.172918_bb0050","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/bph.12329","article-title":"Real-time characterization of cannabinoid receptor 1 (CB1) allosteric modulators reveals novel mechanism of action","volume":"170","author":"Cawston","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.pbb.2020.172918_bb0055","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1021\/acs.jmedchem.5b00579","article-title":"Distinct temporal fingerprint for cyclic adenosine monophosphate (cAMP) signaling of Indole-2-carboxamides as allosteric modulators of the cannabinoid receptors","volume":"58","author":"Cawston","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.pbb.2020.172918_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0361-9230(97)00291-8","article-title":"Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice","volume":"45","author":"Chakrabarti","year":"1998","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.pbb.2020.172918_bb0065","first-page":"973","article-title":"Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1\/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice","volume":"334","author":"Cluny","year":"2010"},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0070","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1124\/jpet.103.062836","article-title":"3-[2-cyano-3-(trifluoromethyl) phenoxy] phenyl-4, 4, 4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1\/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects","volume":"310","author":"De Vry","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11419-018-0404-2","article-title":"Metabolism of the new synthetic cannabinoid EG-018 in human hepatocytes by high-resolution mass spectrometry","volume":"36","author":"Diao","year":"2018","journal-title":"Forensic Toxicol."},{"issue":"16","key":"10.1016\/j.pbb.2020.172918_bb0080","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1021\/jm070317a","article-title":"Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1\/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration","volume":"50","author":"Dziadulewicz","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2020.172918_bb0085","series-title":"EMCDDA-Europol 2014 Annual Report on the Implementation of Council Decision 2005\/387\/JHA, Implementation Reports","author":"EMCDDA","year":"2015"},{"issue":"2\u20133","key":"10.1016\/j.pbb.2020.172918_bb0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugalcdep.2011.01.012","article-title":"Synthetic cannabinoid JWH-018 and psychosis: an explorative study","volume":"117","author":"Every-Palmer","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"15","key":"10.1016\/j.pbb.2020.172918_bb0095","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/bph.13866","article-title":"G\u03b1s signalling of the CB1 receptor and the influence of receptor number","volume":"174","author":"Finlay","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1124\/jpet.117.246983","article-title":"Molecular and behavioral pharmacological characterization of abused synthetic cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA","volume":"365","author":"Gamage","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pbb.2020.172918_bb0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/jpet.118.254425","article-title":"Synthetic cannabinoid hydroxypentyl metabolites retain efficacy at human cannabinoid receptors","volume":"368","author":"Gamage","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.pbb.2020.172918_bb0110","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/FBP.0000000000000093","article-title":"\u03949-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2\/Spice","volume":"25","author":"Gatch","year":"2014","journal-title":"Behav. Pharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2020.172918_bb0115","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00414-018-1911-8","article-title":"Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication","volume":"132","author":"Gaunitz","year":"2018","journal-title":"Int. J. Legal Med."},{"issue":"16","key":"10.1016\/j.pbb.2020.172918_bb0120","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1007\/s00216-019-01837-8","article-title":"In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples","volume":"411","author":"Gaunitz","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.pbb.2020.172918_bb0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1124\/jpet.111.187757","article-title":"JWH-018 and JWH-073: Delta(9)-tetrahydrocannabinol-like discriminative stimulus effects in monkeys","volume":"340","author":"Ginsburg","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"13","key":"10.1016\/j.pbb.2020.172918_bb0130","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1021\/ac300509h","article-title":"Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs","volume":"84","author":"Grabenauer","year":"2012","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/jpet.116.233163","article-title":"Stratification of cannabinoid 1 receptor (CB1R) agonist efficacy: manipulation of CB1R density through use of transgenic mice reveals congruence between in vivo and in vitro assays","volume":"359","author":"Grim","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.pbb.2020.172918_bb0140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1521-0391.2012.00240.x","article-title":"\u201cSpice\u201d and \u201cK2\u201d herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans","volume":"21","author":"Gunderson","year":"2012","journal-title":"Am. J. Addict."},{"issue":"14","key":"10.1016\/j.pbb.2020.172918_bb0145","doi-asserted-by":"crossref","first-page":"10576","DOI":"10.1074\/jbc.M609695200","article-title":"Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate\/G13 pathway","volume":"282","author":"Jiang","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrd722","article-title":"Efficacy at G-protein-coupled receptors","volume":"1","author":"Kenakin","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11419-017-0361-1","article-title":"In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA","volume":"35","author":"Kevin","year":"2017","journal-title":"Forensic Toxicol."},{"issue":"1","key":"10.1016\/j.pbb.2020.172918_bb0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/dta.2262","article-title":"Kinetic and metabolic profiles of synthetic cannabinoids NNEI and MN-18","volume":"10","author":"Kevin","year":"2017","journal-title":"Drug Test. Anal."},{"issue":"5","key":"10.1016\/j.pbb.2020.172918_bb0165","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jms.3761","article-title":"Development of a mass spectrometric hydroxyl-position determination method for the hydroxyindole metabolites of JWH-018 by GC-MS\/MS","volume":"51","author":"Kusano","year":"2016","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.pbb.2020.172918_bb0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pbb.2014.05.010","article-title":"In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Delta9-THC in mice: inhalation versus intraperitoneal injection","volume":"124","author":"Marshell","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172918_bb0175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","article-title":"Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs","volume":"40","author":"Martin","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172918_bb0180","article-title":"Finding order in chemical chaos-continuing characterization of synthetic cannabinoid receptor agonists","author":"Marusich","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2020.172918_bb0185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.302.1.359","article-title":"Characterization of the diarylether sulfonylester (\u2212)-(R)-3-(2-hydroxymethylindanyl-4-oxy) phenyl-4, 4, 4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties","volume":"302","author":"Mauler","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00213-008-1230-8","article-title":"Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol","volume":"203","author":"McMahon","year":"2009","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.pbb.2020.172918_bb0195","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/dta.2398","article-title":"Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples","volume":"10","author":"Mogler","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.pbb.2020.172918_bb0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1432-1327.2001.01810.x","article-title":"CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains","volume":"268","author":"Mukhopadhyay","year":"2001","journal-title":"Eur. J. Biochem."},{"issue":"6","key":"10.1016\/j.pbb.2020.172918_bb0205","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1124\/mol.104.003558","article-title":"Chemically distinct ligands promote differential CB1 cannabinoid receptor-Gi protein interactions","volume":"67","author":"Mukhopadhyay","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172918_bb0210","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"2011"},{"key":"10.1016\/j.pbb.2020.172918_bb0215","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.forsciint.2014.12.029","article-title":"Validation of JWH-018 and its metabolites in blood and urine by UPLC\u2013MS\/MS: monitoring in forensic cases","volume":"248","author":"\u00d6zt\u00fcrk","year":"2015","journal-title":"Forensic Sci. Int."},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0220","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11419-018-0415-z","article-title":"Pharmacological evaluation of new constituents of \u201cSpice\u201d: synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds","volume":"36","author":"Schoeder","year":"2018","journal-title":"Forensic Toxicol."},{"issue":"3","key":"10.1016\/j.pbb.2020.172918_bb0225","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3565(25)20744-3","article-title":"Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands","volume":"278","author":"Showalter","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pbb.2020.172918_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2016","journal-title":"Clin. Toxicol."},{"issue":"1","key":"10.1016\/j.pbb.2020.172918_bb0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.116.238717","article-title":"Thermolytic degradation of synthetic cannabinoids: chemical exposures and pharmacological consequences","volume":"361","author":"Thomas","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMp1505328","article-title":"Synthetic cannabinoid-related illnesses and deaths","volume":"373","author":"Trecki","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.pbb.2020.172918_bb0245","first-page":"855","article-title":"\u201cDangerous drugs\u201d and synthetic cannabinoids","volume":"52","author":"Uchiyama","year":"2016","journal-title":"Farumashia"},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11419-009-0069-y","article-title":"Identification of a cannabimimetic indole as a designer drug in a herbal product","volume":"27","author":"Uchiyama","year":"2009","journal-title":"Forensic Toxicol."},{"issue":"1","key":"10.1016\/j.pbb.2020.172918_bb0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.drugalcdep.2011.07.011","article-title":"A survey study to characterize use of Spice products (synthetic cannabinoids)","volume":"120","author":"Vandrey","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"1\u20133","key":"10.1016\/j.pbb.2020.172918_bb0260","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2009.05.010","article-title":"Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl\/6J mice","volume":"615","author":"Vann","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2020.172918_bb0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0091-3057(99)00059-3","article-title":"Cannabis: discrimination of \u201cinternal bliss\u201d?","volume":"64","author":"Wiley","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2020.172918_bb0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0376-8716(95)01193-5","article-title":"Pharmacological specificity of the discriminative stimulus effects of \u0394 9-tetrahydrocannabinol in rhesus monkeys","volume":"40","author":"Wiley","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2020.172918_bb0275","series-title":"Hijacking of Basic Research: The Case of Synthetic Cannabinoids","author":"Wiley","year":"2011"},{"key":"10.1016\/j.pbb.2020.172918_bb0280","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuropharm.2013.07.022","article-title":"Cannabinoids in disguise: \u0394 9-Tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles","volume":"75","author":"Wiley","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.172918_bb0285","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pbb.2014.05.016","article-title":"Cross-substitution of \u0394 9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats","volume":"124","author":"Wiley","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pbb.2020.172918_bb0290","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.115.225326","article-title":"AB-CHMINACA, AB-PINACA, and FUBIMINA: affinity and potency of novel synthetic cannabinoids in producing \u03949-Tetrahydrocannabinol\u2013like effects in mice","volume":"354","author":"Wiley","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Pt A","key":"10.1016\/j.pbb.2020.172918_bb0295","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2016.07.016","article-title":"Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice","volume":"110","author":"Wiley","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2020.172918_bb0300","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuro.2019.04.002","article-title":"Do you feel it now? Route of administration and Delta(9)-tetrahydrocannabinol-like discriminative stimulus effects of synthetic cannabinoids in mice","volume":"73","author":"Wiley","year":"2019","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.pbb.2020.172918_bb0305","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11419-014-0243-8","article-title":"The \u201cpharmacophore rule\u201d and the \u201cspices\u201d","volume":"33","author":"Worst","year":"2015","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.pbb.2020.172918_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.08.025","article-title":"Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists","volume":"169","author":"Wouters","year":"2019","journal-title":"Biochem. Pharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305720300332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305720300332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:36:52Z","timestamp":1758775012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305720300332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":62,"alternative-id":["S0091305720300332"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172918","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172918"}}